[HTML][HTML] Surgery after conversion therapy with PD-1 inhibitors plus tyrosine kinase inhibitors are effective and safe for advanced hepatocellular carcinoma: a pilot study …
W Zhang, B Hu, J Han, Z Wang, G Ma, H Ye… - Frontiers in …, 2021 - frontiersin.org
Background and Aims Immunotherapy with PD-1 inhibitors combined with tyrosine kinase
inhibitors (TKIs) has been proven to be effective against advanced hepatocellular carcinoma …
inhibitors (TKIs) has been proven to be effective against advanced hepatocellular carcinoma …
Surgery After Conversion Therapy With PD-1 Inhibitors Plus Tyrosine Kinase Inhibitors Are Effective and Safe for Advanced Hepatocellular Carcinoma: A Pilot Study of …
W Zhang, B Hu, J Han, Z Wang, G Ma, H Ye… - Frontiers in …, 2021 - europepmc.org
Results A total of 10 HCC cases with major vascular invasion met the successful conversion
criteria after the combination therapy, and eight patients underwent subsequent salvage …
criteria after the combination therapy, and eight patients underwent subsequent salvage …
Surgery After Conversion Therapy With PD-1 Inhibitors Plus Tyrosine Kinase Inhibitors Are Effective and Safe for Advanced Hepatocellular Carcinoma: A Pilot Study of …
W Zhang, B Hu, J Han, Z Wang, G Ma… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Background and aims Immunotherapy with PD-1 inhibitors combined with tyrosine kinase
inhibitors (TKIs) has been proven to be effective against advanced hepatocellular carcinoma …
inhibitors (TKIs) has been proven to be effective against advanced hepatocellular carcinoma …
Surgery After Conversion Therapy With PD-1 Inhibitors Plus Tyrosine Kinase Inhibitors Are Effective and Safe for Advanced Hepatocellular Carcinoma: A Pilot Study of …
W Zhang, B Hu, J Han, Z Wang, G Ma, H Ye… - Frontiers in …, 2021 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Background and Aims</jats: title>< jats: p> Immunotherapy with
PD-1 inhibitors combined with tyrosine kinase inhibitors (TKIs) has been proven to be …
PD-1 inhibitors combined with tyrosine kinase inhibitors (TKIs) has been proven to be …
[HTML][HTML] Surgery After Conversion Therapy With PD-1 Inhibitors Plus Tyrosine Kinase Inhibitors Are Effective and Safe for Advanced Hepatocellular Carcinoma: A Pilot …
W Zhang, B Hu, J Han, Z Wang, G Ma, H Ye… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Results A total of 10 HCC cases with major vascular invasion met the successful conversion
criteria after the combination therapy, and eight patients underwent subsequent salvage …
criteria after the combination therapy, and eight patients underwent subsequent salvage …